News
Javelin Biotech Technology Powering New Non-Animal Testing Initiative at UConn School of Pharmacy
Javelin Biotech is proud to announce its central role in a new initiative at the University of Connecticut School of Pharmacy aimed at advancing alternatives to animal testing.
UK Roadmap Sets Clear Timelines to Phase Out Animal Testing
Comprehensive roadmap sets clear objectives and regulatory timelines for phasing out animal models
Press Release: Javelin Biotech Strengthens Board with Robin Robinson as Drug Discovery Shifts Towards Human-Based Models
Javelin Biotech appointed Dr. Robin Robinson to its board, reinforcing human-centric drug discovery aligned with the FDA Modernization Act 3.0.
NIH Announces Prioritization of Human-Based Research Technologies
New initiative aims to reduce use of animals in NIH-funded research.
FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs
FDA takes a significant step towards modernizing drug testing by phasing out animal requirements for monoclonal antibodies and other drugs.
Javelin Biotech Publication: Utilization of a Human Liver Tissue Chip for Drug-Metabolizing Enzyme Induction Studies of Perpetrator and Victim Drugs
A translational experimental system to predict clinical clearance values of both perpetrator and victim drugs